Ixico (IXI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.10p
   
  • Change Today:
    -0.15p
  • 52 Week High: 12.75p
  • 52 Week Low: 6.45p
  • Currency: UK Pounds
  • Shares Issued: 92.67m
  • Volume: 0
  • Market Cap: £10.29m
  • Beta: 0.07

Latest ShareCast News

Ixico upbeat on breakthrough with AI imaging platform

By Josh White

Date: Wednesday 12 Feb 2025

(Sharecast News) - Ixico announced further validation of its AI-driven imaging platform IXIQ.Ai in Huntington's disease (HD) research on Wednesday, through its collaboration with the Huntington's Disease Imaging Harmonisation (HD-IH) consortium.

Ixico secures new contract with US-based client

By Iain Gilbert

Date: Tuesday 10 Dec 2024

(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Ixico raises expectations on new contract wins

By Josh White

Date: Wednesday 14 Aug 2024

(Sharecast News) - Medical imaging advanced analytics technology company Ixico said in a trading update on Wednesday that it expected its financial performance to surpass market expectations, driven by new contract wins totaling £5.8m since 31 March.

Ixico reports progress in Huntington's disease i... 29-Jul-2024 ShareCast
Ixico wins £1m research contract 19-Jun-2024 ShareCast
Ixico inks supply agreement with LMI 15-Apr-2024 ShareCast
Ixico warns on 2024 revenue amid contract delays 13-Mar-2024 ShareCast
Ixico CEO to step down by end of year 12-Jan-2024 ShareCast
Ixico full-year earnings could slightly exceed f... 29-Sep-2023 ShareCast
Ixico awarded new £2m, four-year contract 14-Jun-2023 ShareCast
Ixico set to report first-half loss as legacy is... 10-May-2023 ShareCast
Ixico wins £700,000 contract with biotech company 10-Mar-2023 ShareCast
Ixico awarded two-year MRI imaging contract 09-Dec-2022 ShareCast
Full-year revenue set to fall for Ixico 25-Oct-2022 ShareCast
Ixico to extend work on Huntington's disease trial 14-Jun-2022 ShareCast
Ixico joins Huntington's disease research consor... 10-May-2022 ShareCast
Ixico confident after first-half revenues fall 25-Apr-2022 ShareCast
Ixico selected for Huntington's disease detectio... 21-Apr-2022 ShareCast
Ixico wins £0.8m contract with existing US client 08-Mar-2022 ShareCast
Ixico wins contract from new European biopharmac... 08-Feb-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ixico Market Data

Currency UK Pounds
Share Price 11.10p
Change Today -0.15p
% Change -1.33 %
52 Week High 12.75p
52 Week Low 6.45p
Volume 0
Shares Issued 92.67m
Market Cap £10.29m
Beta 0.07

Ixico Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.95% below the market average21.95% below the market average21.95% below the market average21.95% below the market average21.95% below the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Trend
33.17% above the market average33.17% above the market average33.17% above the market average33.17% above the market average33.17% above the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Income Not Available
Growth
79.59% below the market average79.59% below the market average79.59% below the market average79.59% below the market average79.59% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

Ixico Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Ixico Key Personnel

CEO Giulio Cerroni
CEO Bram Goorden

Top of Page